3PBL
Structure of the human dopamine D3 receptor in complex with eticlopride
3PBL の概要
| エントリーDOI | 10.2210/pdb3pbl/pdb |
| 関連するBIRD辞書のPRD_ID | PRD_900001 |
| 分子名称 | D(3) dopamine receptor, Lysozyme chimera, alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose, 3-chloro-5-ethyl-N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-6-hydroxy-2-methoxybenzamide (3 entities in total) |
| 機能のキーワード | structural genomics, psi-2, psi-biology, protein structure initiative, accelerated technologies center for gene to 3d structure, atcg3d, 7tm, g protein-coupled receptor, gpcr, gpcr network, signal transduction, hydrolase, eticlopride, dopamine, neurotransmitter, chimera, t4l fusion, membrane protein, transmembrane, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
| 由来する生物種 | Homo sapiens (human, Bacteriophage T4) 詳細 |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 108672.38 |
| 構造登録者 | Chien, E.Y.T.,Liu, W.,Han, G.W.,Katritch, V.,Zhao, Q.,Cherezov, V.,Stevens, R.C.,Accelerated Technologies Center for Gene to 3D Structure (ATCG3D),GPCR Network (GPCR) (登録日: 2010-10-20, 公開日: 2010-11-03, 最終更新日: 2024-10-16) |
| 主引用文献 | Chien, E.Y.,Liu, W.,Zhao, Q.,Katritch, V.,Han, G.W.,Hanson, M.A.,Shi, L.,Newman, A.H.,Javitch, J.A.,Cherezov, V.,Stevens, R.C. Structure of the human dopamine d3 receptor in complex with a d2/d3 selective antagonist. Science, 330:1091-1095, 2010 Cited by PubMed Abstract: Dopamine modulates movement, cognition, and emotion through activation of dopamine G protein-coupled receptors in the brain. The crystal structure of the human dopamine D3 receptor (D3R) in complex with the small molecule D2R/D3R-specific antagonist eticlopride reveals important features of the ligand binding pocket and extracellular loops. On the intracellular side of the receptor, a locked conformation of the ionic lock and two distinctly different conformations of intracellular loop 2 are observed. Docking of R-22, a D3R-selective antagonist, reveals an extracellular extension of the eticlopride binding site that comprises a second binding pocket for the aryl amide of R-22, which differs between the highly homologous D2R and D3R. This difference provides direction to the design of D3R-selective agents for treating drug abuse and other neuropsychiatric indications. PubMed: 21097933DOI: 10.1126/science.1197410 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.89 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






